Fernandez Henry A — SEC Form 4 filings
SEC reporting owner CIK 1416750. 21 Form 4 filings on record with FilingPulse; latest filed 2026-05-18.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2024-02-07 to 2026-05-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 50 legs across 7 filings — 56,900 shares, $30,122,137 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: purchase of 9,916 shares @ $544.70 ($5,401,245) in MSCI Inc., filed 2025-07-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MSCI Inc. (MSCI) | Chairman and CEO, Director | 13 | 50 legs · 56,900 sh · $30,122,137 | — | 19 |
| Royalty Pharma plc (RPRX) | Director | 8 | — | — | 8 |
Form 4 filings — Fernandez Henry A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-18 | 4 | MSCI Inc. (MSCI) | Purchase (P): 120 @ $559.40 · Purchase (P): 240 @ $560.28 · Purchase (P): 1,238 @ $561.56 · Purchase (P): 1,122 @ $562.47 · Purchase (P): 800 @ $563.39 · Purchase (P): 400 @ $564.42 · +1 more | EDGAR |
| 2026-04-30 | 4 | MSCI Inc. (MSCI) | Gift (G): 75,707 @ $0 · Gift (G): 75,707 @ $0 | EDGAR |
| 2026-02-17 | 4 | MSCI Inc. (MSCI) | Purchase (P): 6,000 @ $524.18 · Purchase (P): 240 @ $517.32 · Purchase (P): 360 @ $519.45 · Purchase (P): 200 @ $520 | EDGAR |
| 2026-01-28 | 4 | MSCI Inc. (MSCI) | Grant/award (A): 42,193 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | MSCI Inc. (MSCI) | Purchase (P): 360 @ $531.98 · Purchase (P): 1,124 @ $533.12 · Purchase (P): 1,043 @ $534.55 · Purchase (P): 3,190 @ $535.51 · Purchase (P): 1,892 @ $536.34 · Purchase (P): 431 @ $537.31 · +13 more | EDGAR |
| 2025-07-28 | 4 | MSCI Inc. (MSCI) | Purchase (P): 9,916 @ $544.70 · Purchase (P): 23 @ $546.40 · Purchase (P): 18 @ $547.49 · Purchase (P): 43 @ $550.41 · Purchase (P): 2,400 @ $535.11 | EDGAR |
| 2025-06-30 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 1,064 @ $35.24 | EDGAR |
| 2025-05-14 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 7,614 @ $0 | EDGAR |
| 2025-04-01 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 1,141 @ $32.87 | EDGAR |
| 2025-02-25 | 4 | MSCI Inc. (MSCI) | Purchase (P): 500 @ $569.86 · Purchase (P): 4,700 @ $574.98 · Purchase (P): 100 @ $575.66 | EDGAR |
| 2025-02-10 | 4 | MSCI Inc. (MSCI) | Grant/award (A): 58,370 @ $0 · Tax withholding (F): 32,279 @ $587.48 | EDGAR |
| 2025-02-04 | 4 | MSCI Inc. (MSCI) | Grant/award (A): 36,846 (derivative) @ $0 · Grant/award (A): 40,780 (derivative) @ $0 · Grant/award (A): 44,920 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | MSCI Inc. (MSCI) | Grant/award (A): 29,564 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 1,503 @ $24.94 | EDGAR |
| 2024-12-09 | 4 | MSCI Inc. (MSCI) | Purchase (P): 600 @ $610 · Purchase (P): 1,807 @ $613.38 · Purchase (P): 493 @ $614.08 | EDGAR |
| 2024-09-30 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 1,342 @ $27.92 | EDGAR |
| 2024-06-28 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 1,399 @ $26.80 | EDGAR |
| 2024-06-10 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 9,293 @ $0 | EDGAR |
| 2024-04-26 | 4 | MSCI Inc. (MSCI) | Purchase (P): 500 @ $459.48 · Purchase (P): 906 @ $460.69 · Purchase (P): 1,445 @ $461.92 · Purchase (P): 863 @ $462.96 · Purchase (P): 1,600 @ $464.55 · Purchase (P): 760 @ $465.74 · +9 more | EDGAR |
| 2024-04-02 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 1,240 @ $30.23 | EDGAR |
| 2024-02-07 | 4 | MSCI Inc. (MSCI) | Grant/award (A): 84,022 @ $0 · Tax withholding (F): 46,465 @ $583.39 · Grant/award (A): 7,298 @ $0 · Tax withholding (F): 4,036 @ $583.39 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1416750 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →